In the same study, conditional activation of HrasᴧV12 in conjunction with constitutional activation of Id1 led to tumor formation, but doxycycline inactivation of the HrasᴧV12 promoter resulted in complete tumor regression within 40 days. Here, ID1 is linked to neoplasm.